Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study

In the transition from normal glucose tolerance (NGT) to type 2 diabetes mellitus (T2DM), the role of beta-cell dysfunction and peripheral insulin resistance (IR) is well established. However, the impact of dysfunctional adipose tissue has not been fully elucidated. The aim of this study was to evaluate the role of resistance to the antilipolytic effect of insulin (adipose tissue IR [Adipo-IR]) in a large group of subjects with NGT, impaired glucose tolerance (IGT), and T2DM. Three hundred two subjects with varying glucose tolerance received an oral glucose tolerance test (OGTT) and euglycemic insulin clamp. We evaluated Adipo-IR (fasting and mean OGTT plasma free fatty acid [FFA] x insulin concentrations), peripheral IR (1/[Matsuda index] and (M/I)(-1) value), and beta-cell function (calculated as the ratio of the increment in plasma insulin to glucose [OGTT/IR (Delta I/Delta G divided by IR)]). Fasting Adipo-IR was increased twofold in obese subjects with NGT and IGT versus lean subjects with NGT (8.0 +/- 1.1 and 9.2 +/- 0.7 vs. 4.1 +/- 0.3, respectively) and threefold in subjects with T2DM (11.9 +/- 0.6; P < 0.001). Progressive decline in Delta I/Delta G 4 IR was associated with a progressive impairment in FFA suppression during OGTT, whereas the rise in mean plasma glucose concentration only became manifest when subjects became overtly diabetic. The progressive decline in beta-cell function that begins in individuals with NGT is associated with a progressive increase in FFA and fasting Adipo-IR.